Radiosensitizing effect of TRPV1 channel inhibitors in cancer cells

Keyphrases

• 53BP1 16%
• A549 Cells 33%
• AMG9810 16%
• Apoptosis 16%
• Apoptotic Cells 16%
• Ataxia Telangiectasia mutated 16%
• Cancer Cells 100%
• Cancer Therapy 16%
• Capsazepine 16%
• Cell Damage 16%
• Cell Synthesis 16%
• Cell Viability 16%
• Channel Inhibitor 100%
• DNA Damage 16%
• DNA Damage Response 16%
• DNA Repair 16%
• DNA Synthesis 16%
• Early Response 16%
• Human Lung Adenocarcinoma Cells 16%
• In Cancer 100%
• Induced Activation 16%
• Irradiation 66%
• Multiple Repair 16%
• Necrosis 16%
• Necrotic Cells 16%
• Non-tumor Tissue 16%
• P53-binding Protein 1 16%
• Proliferative Activity 16%
• Protein Kinase 16%
• Radiation Effects 16%
• Radiation Therapy 16%
• Radiation-induced DNA Damage 16%
• Radioresistant 16%
• Radiosensitization 66%
• Radiosensitizing Effect 100%
• Radiotherapy 16%
• Repair System 16%
• Solid Tumors 16%
• Survival Rate 16%
• Transient Receptor Potential Vanilloid 1 Channel 100%

Medicine and Dentistry

• 4 Chloro N (3 Methoxyphenyl)cinnamamide 16%
• Ataxia Telangiectasia 16%
• Cancer Cell 100%
• Cancer Therapy 16%
• Capsazepine 16%
• Cell Damage 16%
• Cell Viability 16%
• DNA Damage 16%
• DNA Damage Response 33%
• DNA Repair 16%
• DNA Synthesis 16%
• Lung Adenocarcinoma 16%
• N (1,4 Benzodioxan 6 Yl) 3 (4 Tert Butylphenyl)acrylamide 16%
• N (4 Tert Butylphenyl) 4 (3 Chloro 2 Pyridinyl) 1 Piperazinecarboxamide 16%
• Necrosis 16%
• Programmed Cell Death 16%
• Protein Kinases 16%
• Radiation Therapy 33%
• Radiosensitizer 66%
• Solid Malignant Neoplasm 16%
• Tumor Suppressor P53 Binding Protein 1 16%
• Vanilloid Receptor 1 100%

Pharmacology, Toxicology and Pharmaceutical Science

• 4 Chloro N (3 Methoxyphenyl)cinnamamide 16%
• Ataxia Telangiectasia 16%
• Capsazepine 16%
• Cell Viability 16%
• Lung Adenocarcinoma 16%
• Malignant Neoplasm 100%
• N (1,4 Benzodioxan 6 Yl) 3 (4 Tert Butylphenyl)acrylamide 16%
• N (4 Tert Butylphenyl) 4 (3 Chloro 2 Pyridinyl) 1 Piperazinecarboxamide 16%
• Necrosis 16%
• Protein Kinases 16%
• Radiosensitizing Agent 66%
• Solid Malignant Neoplasm 16%
• Tumor Suppressor P53 Binding Protein 1 16%
• Vanilloid Receptor 1 100%